Duarte, Calif.-based City of Hope has received $11 million from the Simms/Mann Family Foundation to support precision oncology research.
The gift will help establish the Simms/Mann Family Foundation Precision Oncology Program in Southern California and endow two chair positions, according to a Nov. 12 news release from City of Hope.
The Simms/Mann Family Foundation Chair in Cancer Microbiome Research will be held by Robert Jenq, MD, who serves as director of City of Hope’s Microbiome Program.
The Simms/Mann Family Foundation Chair in Clinical Cancer Genomics position has not been named but “will be recruited,” the release said.
“The more we understand an individual’s disease and biology, the more precisely we can tailor treatment and care,” John Carpten, PhD, chief scientific officer at City of Hope, said in the release. “Support like this helps accelerate the research that will define the next generation of cancer medicine and expand access to these approaches for patients everywhere.”
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
